Asset Details
Do you wish to reserve the book?
The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit
Do you wish to request the book?
The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit
2019
Overview
Background
Status, refractory status and super refractory status epilepticus are common neurologic emergencies. The objective of this study is to investigate the feasibility, safety and effectiveness of a ketogenic diet (KD) for refractory status epilepticus (RSE) in adults in the intensive care unit (ICU).
Methods
We performed a retrospective, single-center study of patients between ages 18 and 80 years with RSE treated with a KD treatment algorithm from November 2016 through April 2018. The primary outcome measure was urine ketone body production as a biomarker of feasibility. Secondary measures included resolution of RSE and KD-related side effects.
Results
There were 11 adults who were diagnosed with RSE that were treated with the KD. The mean age was 48 years, and 45% (
n
= 5) of the patients were women. The patients were prescribed a median of three anti-seizure medications before initiating the KD. The median duration of RSE before initiation of the KD was 1 day. Treatment delays were the result of Propofol administration. 90.9% (
n
= 10) of patients achieved ketosis within a median of 1 day. RSE resolved in 72.7% (
n
= 8) of patients; however, 27.3% (
n
= 3) developed super-refractory status epilepticus. Side effects included metabolic acidosis, hypoglycemia and hyponatremia. One patient (20%) died.
Conclusions
KD may be feasible, safe and effective for treatment of RSE in the ICU. A randomized controlled trial (RCT) may be indicated to further test the safety and efficacy of KD.
Publisher
Springer US,Springer Nature B.V
Subject
/ Adult
/ Aged
/ Brain Diseases - complications
/ Diet
/ Diet, Ketogenic - adverse effects
/ Drug Resistant Epilepsy - diet therapy
/ Drug Resistant Epilepsy - urine
/ Drugs
/ Epilepsy
/ Female
/ Females
/ Humans
/ Ketosis
/ Male
/ Medicine
/ Outcome Assessment, Health Care
/ Patients
/ Status Epilepticus - diet therapy
/ Status Epilepticus - etiology
/ Stroke
/ Urine
